Related Experiment Video
Updated: Jan 29, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
Innovative Biomaterials Synergize Oncolytic Virus for Elevating Tumor Immunotherapy Potency
Jiaxue Wen1, Shu-Jin Li2, Ruohan Xiao1
1Key Laboratory of Luminescence Analysis and Molecular Sensing, Ministry of Education, School of Materials and Energy, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing, China.
Biomaterials enhance oncolytic virus (OV) therapy for cancer by improving viral delivery and overcoming tumor microenvironment challenges. This combination strategy shows promise for more effective cancer immunotherapy.
Area of Science:
- Biomedical Engineering
- Immunology
- Materials Science
Background:
- Oncolytic viruses (OVs) show promise in cancer immunotherapy by selectively targeting tumor cells and stimulating immune responses.
- OV monotherapy faces challenges like poor delivery, immune suppression within tumors, and rapid clearance.
- Biomaterials offer innovative solutions to overcome these limitations in virotherapy.
Purpose of the Study:
- To review the synergistic combination of biomaterials with oncolytic viruses (OVs) for enhanced cancer immunotherapy.
- To highlight nanomaterial-based and cell-derived biomaterials as key delivery systems.
- To discuss the design, mechanisms, and applications of biomimetic virus-like nanoparticles.
Main Methods:
- Systematic review of literature on biomaterial-OV combinations in cancer therapy.
- Categorization of biomaterials into nanomaterial-based carriers and cell-derived materials.
- Critical discussion of biomimetic virus-like nanoparticles, their principles, mechanisms, and applications.
Main Results:
- Biomaterial delivery systems protect OVs from immune clearance, enable targeted delivery, and control viral release.
- Functionalized biomaterials can modulate the immune system and remodel the tumor microenvironment.
- Biomimetic virus-like nanoparticles represent a significant advancement in this field.
Conclusions:
- Combining biomaterials with OVs offers a powerful strategy to enhance cancer immunotherapy.
- Intelligent biomaterial design is crucial for overcoming OV therapy limitations.
- This approach holds significant potential for clinical translation in cancer treatment.
Related Concept Videos
Tumor Immunotherapy
Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
What are Viruses?
Elevation of Intermediate Points on Vertical Curves
Source And Potency Of Stem Cells

